What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Internal medicine, Gastroenterology, Hepatitis B virus, Immunology and Hepatitis B.
His studies in Gastroenterology integrate themes in fields like Hepatocellular carcinoma, Chronic hepatitis and Prospective cohort study, Surgery.
Hepatitis B virus is the subject of his research, which falls under Virology.
His Hepatitis B research includes elements of Entecavir, HBsAg, cccDNA and Viral load.
The concepts of his HBeAg study are interwoven with issues in Exacerbation and Seroconversion.
The study incorporates disciplines such as Nucleoside analogue and Reverse-transcriptase inhibitor in addition to Lamivudine.
His most cited work include:
- Viral hepatitis B (1691 citations)
- A One-Year Trial of Lamivudine for Chronic Hepatitis B (1620 citations)
- Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B (1026 citations)
What are the main themes of his work throughout his whole career to date?
Ching-Lung Lai mostly deals with Internal medicine, Gastroenterology, Virology, Hepatitis B and Hepatitis B virus.
His study in Internal medicine is interdisciplinary in nature, drawing from both Entecavir and Chronic hepatitis.
Ching-Lung Lai has researched Gastroenterology in several fields, including Liver transplantation, Surgery, Telbivudine and Pathology.
His Virology research includes themes of Genotype and Nucleoside.
His Hepatitis B research incorporates themes from Liver disease, Alanine transaminase, Seroconversion and Viral load.
His research on Hepatitis B virus concerns the broader Immunology.
He most often published in these fields:
- Internal medicine (49.50%)
- Gastroenterology (36.83%)
- Virology (34.10%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (49.50%)
- Gastroenterology (36.83%)
- Hepatitis B (32.66%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Gastroenterology, Hepatitis B, Hepatitis B virus and Virology.
His Internal medicine research integrates issues from Entecavir, HBsAg and Chronic hepatitis.
His studies in Gastroenterology integrate themes in fields like Odds ratio, Cohort and Confidence interval.
His study with Hepatitis B involves better knowledge in Immunology.
His Hepatitis B virus study combines topics in areas such as Viral hepatitis, Adverse effect, Pharmacology and Transplantation.
His Virology study integrates concerns from other disciplines, such as RNA interference, DNA and Arc.
Between 2015 and 2021, his most popular works were:
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (1023 citations)
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. (251 citations)
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg (176 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Ching-Lung Lai mainly investigates Internal medicine, HBsAg, Hepatitis B, Gastroenterology and Hepatitis B virus.
As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Nucleoside analogue and, on occasion, Regression.
He interconnects Entecavir, Viral load and Hepatitis in the investigation of issues within HBsAg.
His Hepatitis B research is under the purview of Immunology.
His biological study spans a wide range of topics, including Hepatocellular carcinoma, Chronic hepatitis, Prognostic models and Fatty liver.
His Hepatitis B virus study is related to the wider topic of Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
